Dec 07 2022 15 mins 6
In this podcast, expert clinicians will revisit an important topic from MS Forum® VIII, the use of current and emerging oral therapies for MS, including the Burton’s tyrosine kinase (BTK) inhibitors.
Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle
1.0x
00:00
00:00
